ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,673Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 223

$445K Total Retail Price of All Prescriptions

Rank: 78 out of 223

329 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 329 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 7,044 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 360 314 1 2
HYDROCODONE-ACETAMINOPHEN 359 299 S3 2 5
FUROSEMIDE 291 246 3 9
SIMVASTATIN 273 234 4 1
LISINOPRIL 270 216 5 4
OMEPRAZOLE 268 209 6 3
POTASSIUM CHLORIDE 233 204 7 12
METFORMIN HCL 206 176 8 7
AMLODIPINE BESYLATE 157 130 9 6
CITALOPRAM HBR 148 139 10 16
GABAPENTIN 134 103 11 10
HYDROCHLOROTHIAZIDE 131 120 12 13
SERTRALINE HCL 117 99 13 21
METOPROLOL SUCCINATE 109 91 14 20
WARFARIN SODIUM 108 104 15 11
ZOLPIDEM TARTRATE 108 81 15 8
LOSARTAN POTASSIUM 100 83 17 14
FENTANYL 98 69 S2 18 91
ALLOPURINOL 85 79 19 28
TIZANIDINE HCL 85 55 19 124
SYNTHROID 84 74 21 35
POLYETHYLENE GLYCOL 3350 82 72 22 69
OXYCODONE HCL 79 43 S2 23 50
PREDNISONE 76 57 24 43
AZITHROMYCIN 71 65 25 44
TORSEMIDE 70 66 26 98
ALENDRONATE SODIUM 70 49 26 19
CIPROFLOXACIN HCL 70 60 26 53
TRIAMTERENE-HCTZ 67 64 29 39
QUETIAPINE FUMARATE 66 54 30 70
TRAZODONE HCL 65 41 31 22
GLIPIZIDE 64 53 32 112
ADVAIR DISKUS 63 52 33 47
CYMBALTA 63 53 33 40
SPIRONOLACTONE 62 43 35 55
TRAMADOL HCL 61 54 36 18
LEVOFLOXACIN 60 46 37 160
MELOXICAM 58 54 38 33
VERAPAMIL ER 56 44 39 89
LANTUS 56 52 39 34
OXYBUTYNIN CHLORIDE 56 55 39 75
NAMENDA 54 52 42 48
METFORMIN HCL ER 53 39 43 41
INSULIN SYRINGE 52 51 44 81
DONEPEZIL HCL 52 49 44 36
ENDOCET 50 17 S2 46 133
HUMALOG 50 47 46 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 7, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.